Doximity (NASDAQ:DOCS) Now Covered by The Goldman Sachs Group

The Goldman Sachs Group assumed coverage on shares of Doximity (NASDAQ:DOCSFree Report) in a research report released on Friday morning, MarketBeat reports. The firm issued a neutral rating and a $58.00 price objective on the stock.

Several other equities analysts have also commented on the company. Canaccord Genuity Group reiterated a “hold” rating and issued a $60.00 target price (up from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Raymond James reaffirmed an “outperform” rating and set a $65.00 price objective (up previously from $37.00) on shares of Doximity in a research note on Friday, November 8th. JPMorgan Chase & Co. boosted their target price on shares of Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a report on Monday, August 19th. Truist Financial upped their price target on shares of Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research report on Thursday, November 14th. Finally, Robert W. Baird increased their price target on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 17th. Eleven research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $51.07.

Get Our Latest Report on Doximity

Doximity Price Performance

NASDAQ:DOCS opened at $52.24 on Friday. The firm has a market cap of $9.75 billion, a PE ratio of 60.05, a P/E/G ratio of 4.09 and a beta of 1.30. The firm has a 50 day simple moving average of $43.71 and a 200-day simple moving average of $34.45. Doximity has a 1-year low of $22.96 and a 1-year high of $61.75.

Institutional Investors Weigh In On Doximity

Several hedge funds and other institutional investors have recently bought and sold shares of DOCS. Swedbank AB bought a new position in Doximity during the 1st quarter worth approximately $91,673,000. FMR LLC boosted its position in Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after acquiring an additional 1,598,602 shares during the period. Capital World Investors grew its stake in shares of Doximity by 250.7% in the first quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock worth $46,143,000 after purchasing an additional 1,225,707 shares in the last quarter. William Blair Investment Management LLC increased its holdings in shares of Doximity by 15.8% during the second quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after purchasing an additional 873,682 shares during the period. Finally, Los Angeles Capital Management LLC raised its stake in shares of Doximity by 6,242.6% during the third quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock valued at $28,359,000 after purchasing an additional 640,612 shares in the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

About Doximity

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Recommended Stories

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.